Market Capitalization of Beta Drugs (BETA)
As of Sept. 18, 2026, Beta Drugs (BETA) market capitalisation is ₹2289.12 Cr ($254.35M), with 1.11 Cr shares outstanding at a current price of ₹2055.20 on NSE, ranking 1136 out of 5367 companies by market cap in our screener. Beta Drugs operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Beta Drugs share price chart.
Market Cap History of Beta Drugs (Last 10 Years)
BETA market capitalisation from year-end NSE closing prices over the last 10 years. View BETA 52-week performance for the annual high/low range and current price position.
End of Year Market Cap History — Beta Drugs
BETA year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Explore BETA true value to estimate fundamental worth using multiple valuation models.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹2289.12 Cr
$254.35M USD
|
₹2055.20 | NSE | +32.67% |
| 2025 |
₹1725.42 Cr
$191.71M USD
|
₹1549.10 | NSE | - |